SCHEMBL8306712

SCHEMBL8306712

Cc1cnc(Cl)nc1C(C#N)c1cccnc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.38
GAA P10253 5/20 0.37
KCNA5 P22460 1/20 0.36
ALDH1A1 P00352 3/20 0.34
RPS6KA5 O75582 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CFTR P13569 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
GOPC Q9HD26 1/20 0.34
KDM4E B2RXH2 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPK9 P45984 1/20 0.33
MAPK10 P53779 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12991029 0.78 RPS6KA5 (0.36) RPS6KA5MAPK9MAPK10
SCHEMBL5622301 0.77 MAPK9 (0.51) CYP19A1GAAALDH1A1CFTRSLC6A2
SCHEMBL8302321 0.73 L3MBTL1 (0.38) GAAALDH1A1MAPK9MAPK10L3MBTL1
SCHEMBL2842596 0.70 CFTR (0.57) CYP19A1KCNA5CFTRSLC6A2SLC6A4
SCHEMBL26273854 0.69 CYP19A1 (0.36) CYP19A1GAATSHRHSD17B10CFTR
SCHEMBL8305395 0.68
SCHEMBL9455449 0.67 CYP19A1 (0.41) CYP19A1GAAKCNA5CFTRSLC6A2
SCHEMBL11837357 0.66 L3MBTL1 (0.44) GAAALDH1A1TSHRMAPK1TAAR1
SCHEMBL5617600 0.66 PIN1 (0.32)
SCHEMBL11630272 0.65 ALDH1A1 (0.42) GAAALDH1A1TSHRMAPK1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633363-B1 PYRIDINYL ACETONITRILES MERCK SERONO SA (CH) 2012-11-07 EP disclosed
US-7855212-B2 Pyridinyl acetonitriles MERCK SERONO SA (CH) 2010-12-21 US disclosed
US-7855212-B2 Pyridinyl acetonitriles MERCK SERONO SA (CH) 2010-12-21 US disclosed
US-20070060594-A1 Pyridinyl acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-03-15 US disclosed
US-20070060594-A1 Pyridinyl acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-03-15 US disclosed
WO-2004098607-A1 PYRIDINYL ACETONITRILES APPLIED RESEARCH SYSTEMS ARS HOLDING N. V. (AN) 2004-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060594-A1 Pyridinyl acetonitriles GSK3B, GSK3A, MAPK3 CYP19A1 2052/4885GAA 2009/4885KCNA5 2968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.